Impact Proteomics, LLC
Biotechnology company · Pittsburgh, Pennsylvania, United States
Impact Proteomics, LLC is a biotechnology company headquartered in Pittsburgh, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. It has received 1 NIH small-business research grant, $320,863 in total. It has reported private securities offerings to the US SEC, most recently $50,000 sold in a notice filed in 2024.
Impact Proteomics at a glance
What does Impact Proteomics do?
US government research funding
1 NIH small-business research grant, $320,863 in total. NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $50,000 sold (2024).
Frequently asked questions about Impact Proteomics
Where is Impact Proteomics headquartered?
Impact Proteomics, LLC is headquartered in Pittsburgh, Pennsylvania, United States.
What does Impact Proteomics do?
Impact Proteomics, LLC is a biotechnology company.
When was Impact Proteomics founded?
The earliest incorporation on record for Impact Proteomics, LLC is in 2017, according to public company registers.
Similar companies
- Krystal Biotech, Inc.Pittsburgh, Pennsylvania, United States
- CytoAgents, Inc.Pittsburgh, Pennsylvania, United States
- Knopp Biosciences LLCPittsburgh, Pennsylvania, United States
- Noveome Biotherapeutics, Inc.Pittsburgh, Pennsylvania, United States
- Cohera Medical IncPittsburgh, Pennsylvania, United States
- Renerva, Inc.Pittsburgh, Pennsylvania, United States
- Carmell Therapeutics CorpPittsburgh, Pennsylvania, United States
- Globin Solutions, Inc.Pittsburgh, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences